Adagene FY Adj. EPS $(0.24) Misses $(0.15) Estimate, Sales $7.671M Beat $1.667M Estimate

4/1/2026
Impact: -50
Healthcare

Adagene (NASDAQ: ADAG) reported a fiscal year adjusted EPS of $(0.24), missing the analyst estimate of $(0.15) by 60%. This represents a 52.94% increase in losses compared to $(0.51) per share in the same period last year. The company achieved quarterly sales of $7.671 million, surpassing the consensus estimate of $1.667 million by 360.26%, and showing a significant increase from $103.204 thousand in the prior year.

AI summary, not financial advice

Share: